Board of Directors

Gary E. Costley Ph.D.
Lead Director; Financial Expert
Mr. Costley currently serves as Managing Partner at C&G Capital and Management, a private investment company, since 2004. He previously served from 2001 to 2004 as chairman and chief executive officer of International Multifoods Corporation and from 1997 to 2001 as its chairman, president and chief executive officer. Dr. Costley currently serves as Chairman of the Board of BlueWillow Biologics, Inc., a private early stage vaccine company. Dr. Costley has also served on the boards of Tiffany & Company, Pharmacopeia Inc., Principal Financial Group Inc., Covance Inc. and Accelrys, Inc. as well as Dean of the Graduate School of Marketing at Wake Forest University. Dr. Costley earned a B.S. in Animal Science and both an M.S. and Ph.D. in Nutrition from Oregon State University.
  • Audit Committee
  • Compensation Committee
  • Nominating and Corporate Governance Committee
John E. Byom
Chairman - Compensation & Talent Committee; Financial Expert
Mr. Byom brings broad financial strategic and operating experience to Prestige Brands Holdings, Inc. His background includes high level positions at The J.M. Smucker Company and International Multifoods Corporation, as well as with Chief Executive Officer of Classic Provisions Inc., a specialty foods distribution company. . Mr. Byom is a graduate of Luther College in Decorah, Iowa. He previously was a member of the Board of Directors of MGP Ingredients and chaired their Audit Committee.
  • Compensation & Talent Committee Chair
  • Nominating and Corporate Governance Committee
Celeste A. Clark, Ph.D.
Dr. Clark has been the principal of Abraham Clark Consulting, LLC, a consulting firm, since November 2011 and consults on nutrition and health policy, regulatory affairs and leadership development. Dr. Clark is also an adjunct professor in the Department of Food Science and Human Nutrition at Michigan State University, where she has served in such position since January 2012. She previously served as Senior Vice President, Global Policy and External Affairs of Kellogg Company, a food manufacturing company, and was the Chief Sustainability Officer until she retired in 2011. She was a member of the Global Executive Management Team and had an accomplished career spanning nearly 35 years in the food industry. At Kellogg Company, she was responsible for the development and implementation of health, nutrition and regulatory science initiatives globally to ensure consistency in approach and implementation. In addition, she also led global corporate communications, public affairs, philanthropy and several administrative functions. During the past five years, she has served on the boards of several public and privately held companies including Mead Johnson Nutrition Company, a pediatric nutrition company, beginning in 2011 until being acquired by Reckitt Benckiser plc in 2017; Diamond Foods, Inc., a leading branded snacks supplier, beginning in 2014 until being acquired by Snyder’s-Lance, Inc. in 2016; AdvancePierre Foods Holdings, Inc., a producer and distributor of ready-to-eat sandwiches, beginning in 2016 until being acquired by Tyson Foods, Inc. in 2017; and Omega Protein Corporation, a manufacturer of fish meal and fish oils, until being acquired in 2017 by Cooke, Inc. In 2017, Dr. Clark was elected to the board of directors of Hain Celestial, Inc., and in 2018 to Wells Fargo & Company. She also serves as a trustee of the W.K. Kellogg Foundation. She earned her Bachelor of Science degree from Southern University, Master of Science from Iowa State University, and Ph.D. in Food Science and Nutrition from Michigan State University.
Christopher J. Coughlin
Chairman - Audit Committee; Financial Expert
Mr. Coughlin was appointed to the board in July, 2019.  Previously Mr. Coughlin served as Senior Advisor to the CEO and Board of Directors of Tyco International, Ltd., a diversified holding company, from 2010 until 2012. Prior to that, he was Executive Vice President and Chief Financial Officer of Tyco International from 2005 to 2010. Prior to joining Tyco, he worked in the Chief Operating Officer and Chief Financial Officer roles of the Interpublic Group of Companies as well as Executive Vice President and Chief Financial Officer role of Pharmacia Corporation from 1998 until its acquisition by Pfizer in 2003.

Mr. Coughlin earned a bachelor’s degree in Accounting from Boston College. Mr. Coughlin currently serves on the board of Alexion Pharmaceuticals, Inc. as well as Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company. Formerly, Mr. Coughlin served on the board of Allergan plc, including as Lead Independent Director beginning in October 2016, up until its acquisition by AbbVie in 2020. He also previously served on the boards of The Dun & Bradstreet Corp, Hologic, Inc., Covidien Ltd, Dipexium Pharmaceuticals, Inc., Forest Laboratories, Inc., Interpublic Group of Companies, Monsanto Company and Perrigo Company.
  • Nominating and Corporate Governance Committee
  • Audit Committee Chair
  • Compensation Committee
Sheila A. Hopkins
Ms. Hopkins was named a director in 2015. Ms. Hopkins served as EVP and President, Global Vision Care for Bausch + Lomb, a healthcare company, from 2011 until her retirement in 2013. Prior to that, she spent 14 years at Colgate-Palmolive, a consumer products company, where she held several senior management positions including Vice President and General Manager, Personal Care, and Vice President, Global Business Development from 1997 to 2011. She has also held marketing and sales positions at Procter & Gamble, American Cyanamid and Tambrands. Ms. Hopkins earned a B.A. in History from Wellesley College. She served on the Board of Directors of Warnaco Inc., a leading apparel company, from 2003 to 2013, and on the Board of the Consumer Healthcare Products.
  • Audit Committee
  • Compensation Committee
  • Nominating and Governance Committee
James M. Jenness
Chairman - Nominating and Corporate Governance Committee; Financial Expert
Mr. Jenness was appointed to the board in 2015. Mr. Jenness is the retired Chairman of the Board and CEO of the Kellogg Company, a producer of cereal and convenience foods. He served as Kellogg’s Chairman from 2005 to 2014, as CEO from 2004-2006, and as a director since 2000. He has also served as a director of Kimberly-Clark Corporation from 2007 until 2019. Mr. Jenness’ background also includes serving as CEO of Integrated Merchandising Systems, LLC, a retail promotion and merchandising company, and a 22 year career with Leo Burnett Company, Inc., the global advertising agency, where he last served as Vice Chairman and COO. He is also Senior Director of Children’s Memorial Hospital and Director of Mercy Home for Boys and Girls.
  • Audit Committee
  • Compensation Committee
  • Nominating and Governance Committee Chair
Ron Lombardi
Chairman of the Board, President & CEO
Mr. Lombardi currently serves on the board of ACCO Brands Corporation.

Ron Lombardi was named President and CEO on June, 2015 after serving as Chief Financial Officer since 2010. He was subsequently elected Chairman of the Board in May 2017. He brings extensive financial management experience to the position, with expertise in acquisitions and divestitures, debt and equity structuring, and building financial infrastructure. He served as CFO for Waterbury International Holdings, a private equity-owned firm. Prior to that, he was with the Cannondale Sports Group/Dorel Recreation and Leisure, a consumer sporting equipment and apparel company, in positions of increasing financial responsibility, beginning as CFO and then as Chief Operating Officer. Also included in his background are leadership positions in finance at Gerber Scientific and Emerson Electric, two large publicly traded companies. Mr. Lombardi is currently a member of the Board of Directors at ACCO Brands Corporation.
Natale S. Ricciardi
Mr. Ricciardi , Retired President, Pfizer Global Manufacturing and SVP of Pfizer Inc., was elected to the Board of Directors in 2016. Mr. Ricciardi spent his entire 39 year career at Pfizer Inc., a biopharmaceutical company, until his retirement in 2011. He was responsible for all of Pfizer’s internal and external supply organization, a global enterprise of more than 100 manufacturing facilities. He earned a degree in Chemical Engineering from The City College of New York and an MBA in Finance and International Business from Fordham University. Mr. Ricciardi currently serves on the boards of directors of Dynavax Technologies Corporation, a commercial-stage biopharmaceutical company, and Rapid Micro Biosystems, Inc., a commercial stage company involved in the automation and rapid detection of microbial contamination in manufacturing operations. He also sits on the Strategic Advisory Board of HealthCare Royalty Partners, an investment company.
  • Audit Committee
  • Nominating Committee
  • Compensation Committee
Dawn M. Zier
Financial Expert
Ms. Zier was appointed to the board in May 2020.  Ms. Zier was formerly the  President and CEO of Nutrisystem, a leading provider of weight loss solutions and services, from November 2012 until its March 2019 acquisition by Tivity Health. Ms. Zier then joined Tivity Health, a leading provider of nutrition, fitness, and social engagement solutions, serving as President and a member of its Board of Directors, to help with the integration efforts through December 2019. Prior to that she held a variety of executive positions including President of International, President of Europe and President of Global Consumer Marketing at Reader’s Digest Association, a global media and data marketing company.
Ms. Zier also serves on the boards of The Hain Celestial Group, Inc. and Spirit Airlines where she chairs the Nominating and Corporate Governance Committees. She previously served on the board of Velo Holdings. Ms. Zier earned her MBA and Masters of Engineering from the Massachusetts Institute of Technology. 

Primary IR Contact
Prestige Consumer Healthcare Inc.
660 White Plains Road – Ste 250
Tarrytown, NY 10591
Telephone: 914-524-6819

Transfer Agent

6201 15th Avenue
Brooklyn, NY 11219
Telephone: (800) 937-5449


Stay up to date with investor news, stock information and SEC filings.
Subscribe »